Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer
Study data from Emory University, Medical Department provide new insights into cancer
November 6th, 2008
"The nuclear factor-kappa B (NF-kappa B) signaling pathway has been targeted for therapeutic applications in a variety of human diseases, includuing cancer. Many naturally occurring substances, including curcumin, have been investigated for their actions on the NF-kappa B pathway because of their significant therapeutic potential and safety profile," researchers in the United States report. "A synthetic mono-ketone compound termed 3,5-bis(2-flurobenzylidene) piperidin-4- one (EF24) was developed from curcumin and exhibited potent anticancer activity. Here, we report a mechanism by which EF24 potently suppresses the NF-kappa B signaling pathway through direct action on I...
Source: Women's Health Weekly (2008-11-06)
|
